Pfiz­er in­vests $98M in Aus­tralian man­u­fac­tur­ing to help de­vel­op new an­timi­cro­bial treat­ments

Pfiz­er has al­lo­cat­ed 150 mil­lion Aus­tralian dol­lars (around $98 mil­lion) to in­stall up­grades and build a new man­u­fac­tur­ing fa­cil­i­ty at its ex­ist­ing site in Mel­bourne …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER